Publication | Closed Access
Prognostic value of coronary multidetector CT angiography in patients with an intermediate probability of significant coronary heart disease
20
Citations
11
References
2010
Year
DiagnosisSignificant StenosisDual-source CtCoronary Artery DiseaseAcute Myocardial InfarctionNon-significant StenosisPublic HealthCardiologyAtherosclerosisCardiac ImagingRadiologyCardiovascular ImagingMyocardial InfarctionVascular ImageMedical ImagingCoronary MdctaDigital Subtraction AngiographyCoronary Heart DiseaseCardiovascular DiseaseIntermediate ProbabilityCoronary UnitPrognostic ValueMedicineEmergency Medicine
The aim of this study was to determine the prognostic value of coronary multidetector CT angiography (MDCTA) in patients with an intermediate pre-test probability of significant coronary artery disease (CAD). Patients who underwent 64-slice coronary MDCTA and met the selection criteria were identified and assessed for intermediate pre-test probability. Coronary MDCTA scans were preceded by calcium scoring, whereas all MDCTA scans were interrogated for the presence of plaque composition and the distribution and degree of stenosis. Significant stenosis was classified as being >50% of the luminal diameter. All patients were followed up for the occurrence of (i) cardiac death, (ii) non-fatal myocardial infarction, (iii) unstable angina requiring hospital admission and (iv) revascularisation. 138 patients were included (follow-up of 19.9 months); of these, 8 had a cardiac event (all revascularisations) and all had a positive coronary MDCTA. Patients with normal coronary arteries or non-significant stenosis suffered no cardiac events during follow-up. There were significant differences between the two groups regarding the presence of significant stenosis (p<0.001), the presence of plaque (p = 0.011) and a calcium score >10 (p = 0.003); 36.4% of patients with significant stenosis underwent revascularisation. In conclusion, this is the first UK study to investigate survival data in a population of intermediate-risk patients with no prior history of CAD who were investigated with coronary MDCTA. Coronary MDCTA can confidently rule out significant CAD in the intermediate-risk population and guide risk factor modification in patients with demonstrated coronary atheroma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1